Euro 500 million in revenue family owned pharmaceutical company commercializing lipid lowering drugs and wound plasters.
Provide strategic and operational direction for key R&D projects in Immunology. Realize Euro 6 million sales in North Germany and lead Sales Team to first position in Euro 16 million German affiliate.
Advised Immunology project team on forecasting, financial viability (Net Present Value) and commercialization. As Head of Development Unit accountable for project progress with focus on strategy, board briefings, marketing plans. Reported to CEO.
- Pushed two Immunology molecules into clinical phase.
- Allocated R&D Euro 15 million Immunology budget to projects with highest return-on-investment.